Metropolitan Life Insurance Company (MetLife)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,791
| Closed | -$573K | – | 2404 |
|
|
2022
Q3 | $573K | Buy |
3,791
+38
| +1% | +$5.74K | 0.03% | 462 |
|
|
2022
Q2 | $547K | Buy |
3,753
+264
| +8% | +$38.5K | 0.02% | 485 |
|
|
2022
Q1 | $414K | Sell |
3,489
-10,669
| -75% | -$1.27M | 0.01% | 578 |
|
|
2021
Q4 | $1.95M | Sell |
14,158
-379
| -3% | -$52.2K | 0.03% | 549 |
|
|
2021
Q3 | $2.02M | Buy |
+14,537
| New | +$2.02M | 0.03% | 502 |
|
|
2021
Q2 | – | Sell |
-13,055
| Closed | -$892K | – | 2973 |
|
|
2021
Q1 | $892K | Sell |
13,055
-450
| -3% | -$30.8K | 0.01% | 1033 |
|
|
2020
Q4 | $1.16M | Sell |
13,505
-665
| -5% | -$57K | 0.02% | 783 |
|
|
2020
Q3 | $921K | Sell |
14,170
-204
| -1% | -$13.3K | 0.02% | 794 |
|
|
2020
Q2 | $1.05M | Buy |
14,374
+1,829
| +15% | +$134K | 0.02% | 711 |
|
|
2020
Q1 | $427K | Buy |
12,545
+292
| +2% | +$9.94K | 0.01% | 1142 |
|
|
2019
Q4 | $667K | Sell |
12,253
-343
| -3% | -$18.7K | 0.01% | 1153 |
|
|
2019
Q3 | $526K | Buy |
12,596
+2,183
| +21% | +$91.1K | 0.01% | 1260 |
|
|
2019
Q2 | $456K | Hold |
10,413
| – | – | 0.01% | 1363 |
|
|
2019
Q1 | $536K | Hold |
10,413
| – | – | 0.01% | 1247 |
|
|
2018
Q4 | $385K | Hold |
10,413
| – | – | 0.01% | 1371 |
|
|
2018
Q3 | $391K | Buy |
+10,413
| New | +$391K | 0.01% | 1540 |
|